Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BB-1701 |
Synonyms | |
Therapy Description |
BB-1701 is an antibody-drug conjugate (ADC) comprising an antibody targeting ERBB2 (HER2) conjugated to eribulin, which potentially induces cytotoxicity against tumor cells expressing ERBB2 (HER2) and leads to inhibition of tumor growth (Cancer Res (2023) 83 (7_Supplement): 1887). |